Phase II Trial of Oxaliplatin in Combination With S-1(SOX) in Patients With Recurrent or Metastatic Breast Cancer

Mise à jour : Il y a 4 ans
Référence : NCT00527930

Femme et Homme

Extrait

Phase II trial of oxaliplatin in combination with S-1(SOX) in patients with recurrent or metastatic breast cancer (MBC) previously treated with or resistant to an anthracycline and taxane


Critère d'inclusion

  • Breast Neoplasms

Liens